JPMorgan China A Research Enhanced Index Equity (E (JRCD) 18.409 GBP (%) | Asset Management London Stock Exchange

Chinese A-shares equity fund with active, research-driven management, aiming to outperform the benchmark index through quantitative and fundamental analysis.

Comment

Performance & Momentum

6 Months 98.86 %

1 Year 98.61 %

3 Years 98.77 %

5 Years 99.00 %

Momentum

Unlock this indicator

Strategic Analysis

JPMorgan China A Research Enhanced Index Equity is a Chinese A-shares equity fund that combines an active approach, quantitative research, and fundamental analysis to seek to outperform its benchmark. Its positioning is based on disciplined stock selection within the Chinese domestic market, with an ESG overlay that may appeal to investors looking for a more structured emerging-market exposure.

Strengths

Targeted access to Chinese A-shares, a broad but still complex segment for individual investors to analyze
Active management approach supported by research, which may add value compared with simple index replication
Integration of an ESG filter and a quantitative framework, useful for combining management discipline with more selective stock picking

Weaknesses

High dependence on the Chinese economic cycle and the specific risks of emerging markets, including regulatory and macroeconomic risks
More mixed long-term track record, reminding investors that outperformance is not consistent and can be cyclical

Momentum

Momentum is favorable and reflects a recent trend that is clearly stronger than over the long term. The current trend suggests renewed interest in exposure to Chinese A-shares, with a visible improvement in the performance profile over the short and medium term, but the fund remains sensitive to the Chinese market environment and to the manager’s ability to extend this positive phase.

Analysis performed 1 month ago